That gap has now been substantially closed. A team of researchers led by Marco Jost of Harvard Medical School, working alongside colleagues including Seth Rakoff-Nahoum, Emily Balskus of Harvard University and the Howard Hughes Medical Institute, and Michael Fischbach of Stanford University, has deployed genome-scale CRISPR screening to systematically identify the regulators of AHR signaling in a human hepatocyte model. The study, published in Genome Biology, represents one of the most comprehensive efforts to date to chart the wiring diagram of this enigmatic receptor. Rather than examining candidate genes one at a time, the team perturbed virtually every gene in the human genome and measured the consequences for AHR activity, allowing the data to reveal the regulatory architecture on an unbiased, genome-wide scale.

The technical approach at the heart of the study is CRISPR interference, or CRISPRi, a refined application of the gene-editing technology that does not cut DNA. Instead, a catalytically dead form of the Cas9 protein is guided to specific genes, where it acts as a reversible brake on transcription, silencing expression without altering the underlying genetic code. By delivering a genome-wide library of guide RNAs into cells engineered so that AHR activation produces a measurable fluorescent or luminescent readout, the researchers could simultaneously test the effect of losing each of roughly twenty thousand human genes on the signaling pathway. Genes whose silencing boosted the readout are candidate negative regulators of AHR; those whose silencing dampened the signal are candidate positive regulators. The beauty of the method lies in its parallelism: thousands of regulatory hypotheses are tested in a single experiment, and the strength of each guide RNA’s enrichment or depletion across the population quantifies the effect.

The results provided immediate validation that the screens had captured genuine biology. Among the hits recovered were the core components of the canonical AHR pathway itself, including the receptor, its nuclear translocator partner ARNT, and factors involved in ligand binding and receptor degradation. This internal consistency mattered, because a screen that failed to rediscover the known players could not be trusted to reveal unknown ones. But beyond the expected genes, the datasets surfaced a large and previously unmapped network of regulators, many of which had never been connected to AHR biology. The breadth of the hit list carried its own message: AHR signaling is not an isolated detoxification circuit but a process deeply interwoven with the general machinery of human cells, touching protein synthesis, trafficking, degradation, and chromatin regulation.

One of the study’s most striking findings concerns the fate of the receptor protein itself. The team identified the E3 ubiquitin ligase UBR5 as a factor that sustains AHR signaling by counteracting the degradation of ligand-bound AHR. Ubiquitin ligases are the enzymes that tag proteins with ubiquitin marks, often condemning them to destruction by the proteasome, and the interplay between AHR and the ubiquitin-proteasome system has long been known to shape receptor levels. What the new work adds is a specific, experimentally validated node within that system: when UBR5 function was compromised, ligand-activated AHR was degraded more readily, and the downstream transcriptional program weakened. In other words, UBR5 acts as a guardian of the activated receptor, extending the window during which AHR can drive gene expression after it encounters its chemical triggers.

The screens also probed how regulation depends on context, a question of particular importance for a receptor that responds to chemically diverse ligands ranging from environmental toxins to microbially derived metabolites such as urolithins, the gut bacterial products that the team included in their chemical analyses. By repeating CRISPRi screens with different inducing molecules, the researchers could classify regulators into those that act generally across all ligands and those whose effects are specific to particular inducers. This distinction is more than a technical curiosity. General regulators represent the pathway’s universal infrastructure, while ligand-specific and cell-type-specific regulators offer potential points of selective manipulation. A drug aimed at a general node would shift AHR activity everywhere; one aimed at a context-specific node could, in principle, tune the receptor’s response to microbial metabolites in the gut without disturbing its detoxification duties in the liver.

That therapeutic logic runs throughout the study’s conclusions. Because AHR sits at the interface of environment, diet, microbiome, and immunity, pharmaceutical interest in the receptor has grown steadily, with attempts to modulate it for inflammatory bowel disease, autoimmune conditions, and metabolic disorders. The obstacle has always been specificity: blunt activation or inhibition of AHR produces widespread effects, some beneficial and some harmful. By identifying cell-type-specific and ligand-specific regulatory components, the new map provides a catalog of candidate targets for more surgical interventions. The authors frame these context-dependent nodes as potential handles for manipulating AHR signaling in a targeted manner for therapeutic benefit, a framing that turns a basic-science dataset into a starting point for drug discovery.

The study also carries implications for understanding host-microbe interactions, one of the most active frontiers in biology. Gut bacteria generate a pharmacopeia of small molecules, and AHR is one of the principal receptors through which these metabolites communicate with the host immune system. Microbial ligands of AHR have been implicated in maintaining the intestinal barrier, calibrating immune responses, and protecting against colitis. A complete regulatory map of the pathway in human cells gives researchers a systematic way to ask how host genetics shapes sensitivity to microbial chemistry, and why individuals or disease states might differ in their responses to the same bacterial metabolites. The integration of chemical screening with genetic screening in this work, including the use of a urolithin library prepared specifically for the study, exemplifies the kind of combined approach that the field of host-microbe chemical biology increasingly demands.

Methodologically, the work demonstrates how far functional genomics has come in dissecting signaling pathways that were once studied gene by gene over decades. The researchers supplemented their primary genome-wide screens with focused sublibrary screens, individual validation assays using independently designed guide RNAs, transcriptional measurements, and biochemical analyses of receptor protein turnover, including western blot experiments documented with full-length unprocessed scans. The classification of hits by activation phenotype across multiple inducers, and the assessment of regulator activity across different cell types, turned a flat list of genes into a structured network with layers of general, ligand-specific, and cell-type-specific control. The datasets, released openly with the article, include raw and analyzed screen data, guide RNA sequences, and primer sequences, providing a resource that other laboratories can mine and reanalyze.

What emerges from the study is a picture of AHR as a receptor embedded in a dense web of cellular governance, its activity shaped not only by which ligand is present but by an extensive cast of proteins controlling its expression, abundance, localization, and longevity. The identification of UBR5 as a protector of the activated receptor offers a mechanistic vignette of how that governance works at the level of protein stability, while the broader network suggests that perturbations far removed from the canonical pathway could nonetheless modulate how human cells respond to the chemical world. For a receptor whose dysfunction has been tied to metabolic and inflammatory disease, and whose normal function depends on a constant dialogue between the body and its microbial inhabitants, the new regulatory map is both a reference atlas and a hypothesis engine. It transforms AHR from a well-studied but incompletely understood sensor into a system whose vulnerabilities and control points can, for the first time, be surveyed in their entirety.

Subject of Research: Genome-scale CRISPR identification of regulators of aryl hydrocarbon receptor signaling in human cells

Article Title: Identification of regulators of aryl hydrocarbon receptor signaling in human cells by genome-scale CRISPR screening

Article References: Verma, M., Adamthwaite, M. L., Desai, K., Ding, Y., Wang, X., Bae, M., Rakoff-Nahoum, S., Balskus, E. P., Fischbach, M. A., & Jost, M. (2026). Identification of regulators of aryl hydrocarbon receptor signaling in human cells by genome-scale CRISPR screening. Genome Biology. https://doi.org/10.1186/s13059-026-04299-1

Image Credits: AI Generated

DOI: 10.1186/s13059-026-04299-1

Keywords: aryl hydrocarbon receptor, CRISPR screening, gene regulation, transcription factor, UBR5, E3 ubiquitin ligase, gut microbiome, microbial metabolites, xenobiotic detoxification, host-microbe interactions, inflammatory disease, hepatocytes

The worms in question belong to a group of gutless marine oligochaetes, thin, short animals smaller than a pinhead that live in sediments in tropical and temperate seas around the world. Their name is not an exaggeration. Over the course of evolution, these worms have lost their mouth, their gut and their excretory organs entirely. They cannot eat in any conventional sense, and they have no way of disposing of metabolic waste on their own. Instead, they host dense communities of chemosynthetic bacteria directly beneath their skin. These bacterial tenants fix carbon from compounds such as sulfide, provide the worm with nutrition, and process the host’s waste products. The association is so tight that neither partner can persist without the other: the worm is a walking, burrowing habitat, and the bacteria are its kitchen and its waste treatment plant rolled into one.

Given this level of interdependence, one might expect the partnership to be locked in place, with each worm species bound to a fixed, unchanging set of bacterial partners. The new study shows that the reality is more nuanced and, in some ways, the opposite of what intuition would predict. Within a single worm species, the bacterial communities are indeed very consistent. Worms of the same species collected from ocean regions far apart from one another harbor the same, or very similar, suites of symbionts. At the level of the species, the partnership looks rock solid, as stable as any mutualism described in the literature.

But that stability dissolves the moment researchers compare different host species, even ones that are close evolutionary relatives. Closely related worm species often host very different bacterial communities, tailored to the specific conditions of their local habitat. The authors use the market metaphor to make sense of this pattern: a shopper visiting a market in a different city will still find staple foods, fruits and vegetables, but the specific basket they assemble will reflect local supply and local preferences. In the same way, each worm species solves its nutritional needs with a specific, locally adaptive community of symbionts. The functional requirements of the partnership remain constant, while the identities of the partners providing those functions can change dramatically from one host lineage and one location to another.

Even more surprising is what the study reveals about fidelity over time. The worms do not simply inherit a fixed bacterial community and pass it on unchanged. They regularly take up new symbionts from their environment, and occasionally they drop some of the ones they already carry. As Mankowski reports, the worms like to try out new market stalls every now and then, adjusting to the local supply. This ongoing turnover means that the symbiosis is not a closed, hermetically sealed system but an open, dynamic marketplace in which partners are continually recruited, tested and, in some cases, released. The community as a whole remains stable in its overall composition and function, while its individual members come and go.

Why would an animal that is utterly dependent on its bacteria take the apparent risk of not being completely loyal to them? Dubilier, who has studied these partnerships for decades, admits that the pattern was genuinely surprising, since dependence on a partner would seem to demand unwavering fidelity. The most plausible answer lies in the diversity of metabolic abilities among the bacterial partners. Each symbiont species brings a different set of biochemical skills to the table. By periodically acquiring new bacteria, a worm can tap into new sources of food and energy, expanding its metabolic repertoire. In habitats where nutrients are sometimes scarce or fluctuate over time, this ability to sample and incorporate new metabolic capabilities could make the difference between thriving and merely surviving. Flexibility, in other words, is not a weakness in the partnership but a form of insurance.

The evidence behind these conclusions is unprecedented in scale. The researchers analyzed samples collected during three decades of expedition work, spanning nearly 250 worms representing 63 species from 17 different locations across the world’s oceans. No comparable survey of these symbioses has ever been attempted before. A dataset of this breadth was essential for separating genuine patterns from local accidents: only by comparing worms across species, regions and habitats could the team demonstrate that community stability within species coexists with dramatic turnover between species and through time.

The study also owes its existence to a quiet revolution in laboratory technology. Gruber-Vodicka, who led the project at the Max Planck Institute in Bremen and now runs his own laboratory at Kiel University, recalls that the first and seminal metagenomic analyses of gutless oligochaetes required thousands of worms to yield enough genetic material for a single analysis, a constraint that made comparative work across species and locations practically impossible. Recent technical innovations have changed that equation completely. Today, researchers can work with single individuals of animals smaller than a pinhead, recovering the genomes of their symbionts and reconstructing the metabolic potential of entire bacterial communities from one worm at a time. That leap in sensitivity is what transformed a long-standing question about symbiotic stability into an answerable one.

The broader significance of the work extends well beyond these particular worms. Symbioses between animals and chemosynthetic or nutritional bacteria are widespread in nature, from deep-sea tube worms and hydrothermal vent mussels to insects fed by bacterial endosymbionts, and a central puzzle in evolutionary biology has been how such intimate dependencies persist over millions of years without becoming brittle. The new study suggests a general principle: stability in symbiosis need not come from rigidity. A partnership can remain functionally stable even as its membership changes, provided the exchange of benefits continues. The worms are loyal partners to their bacteria in the short term, but always open to new possibilities in the long run, and that combination of commitment and adaptability keeps the relationship resilient as environments shift.

The evolutionary success of this strategy is written in the worms’ distribution. Despite an apparently restrictive lifestyle, lacking a mouth, a gut and excretory organs, and depending entirely on microbial partners for nutrition and waste management, gutless oligochaete communities have colonized all the world’s oceans and an impressive variety of habitats, from carbonate sands in Belize to sediments far beyond the tropics. Their shifting alliances, maintained over roughly 150 million years of evolution, have proven to be a remarkably durable recipe. In the marketplace of symbiosis, it turns out, the most stable customers are not those who never change their stalls, but those who know exactly what they need while remaining willing to shop around for it.

Subject of Research: Stability and flexibility of bacterial symbioses in gutless marine worms

Article Title: A symbiotic marketplace: Stability through flexibility

Article References: A symbiotic marketplace: Stability through flexibility. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: symbiosis, marine worms, microbiome, metagenomics, chemosynthetic bacteria, Science Advances, Max Planck Institute for Marine Microbiology, host-microbe interactions, evolution, biodiversity, oligochaetes, nutrient exchange

IgA is the most abundantly produced antibody in the human body, secreted in staggering quantities across mucosal surfaces every day. In the gut, it binds to bacteria, archaea, and other residents, coating some microbes heavily while leaving others untouched. This selective binding is thought to influence which organisms persist, where they localize, and how they interact with the host epithelium. Despite decades of work in mucosal immunology, however, IgA targeting has rarely been treated as a formal, quantitative dimension of microbiome analysis. Standard metagenomic studies measure abundance and diversity; they do not ask how actively the immune system is engaging each species. The new work sets out to close that gap.

The team’s central methodological innovation is the Species Immune Engagement Score, abbreviated IM-score. Rather than relying on IgA binding alone, the score integrates three distinct features for each microbial taxon: the intensity of IgA binding to that organism, its abundance in the community, and its prevalence across individuals in a cohort. The logic is that a microbe only registers as immunologically engaged if it is both recognized by antibodies and consistently present at meaningful levels across a population — a design intended to separate genuine, reproducible immune targeting from transient binding events or artifacts of low-abundance detection. The result is a per-species numerical measure of how hard the immune system is working against each resident of the gut.

When the researchers applied IM-score across three geographically distinct human cohorts, a striking pattern emerged: a conserved set of IgA-targeted gut microbes appeared across all three populations. This set included well-characterized commensal bacteria such as Coprococcus comes, a species frequently associated with short-chain fatty acid production, as well as poorly characterized taxa such as an Oscillospiraceae species designated SGB15216, which has no established functional profile in the literature. The implication is that immunological relevance and scientific characterization have diverged — some of the microbes the immune system engages most actively are precisely the ones microbiome research has paid the least attention to.

To move from individual species to community-level organization, the team aggregated IM-score values into a second metric, the Immunologically Engaged Gut Microbiota Index, or IMG-index. Where IM-score describes how strongly the immune system targets a single taxon, IMG-index summarizes the overall state of IgA-mediated engagement across the entire community. Conceptually, the index functions as a readout of how coherently the immune system is surveying the gut: a high, structured engagement pattern suggests an organized surveillance program, while fragmentation suggests the immune system’s relationship with the microbiota has been disrupted.

The clinical test case was early multiple sclerosis, a disease in which gut microbiome alterations have been repeatedly reported but mechanistically remain murky. Applying the new framework to people with early-stage disease, the researchers found a profound fragmentation of IgA-mediated immune engagement, particularly affecting short-chain fatty acid-producing bacteria and the dominant archaeal lineage in the gut. This is a notable finding because short-chain fatty acids are central players in immune regulation and gut-brain signaling, and their producing organisms have been implicated in MS-associated inflammation before. Crucially, the authors report that these fragmentation patterns are not captured by standard diversity or compositional metrics — meaning a conventional metagenomic analysis could look at the same samples and miss the immune-level disruption entirely.

The sensitivity of IMG-index extended beyond cross-sectional differences. The researchers tracked the index through fecal microbiota transplantation, a therapeutic intervention increasingly studied for its potential to reshape disease-associated microbiomes, and found that it registered changes following the procedure. The index also fluctuated with disease activity, suggesting it is not a static marker of diagnosis but a dynamic measure that responds as the immune-microbiota relationship shifts. Taken together, these observations position IMG-index as a candidate monitoring tool — one that could, in principle, track both disease-associated alterations and responses to microbiome-directed therapies over time.

Technically, the framework rests on the combination of IgA-seq-style binding measurements with deep metagenomic sequencing, allowing the team to quantify antibody coating and species identity simultaneously. The authors also report robustness analyses showing that the immune engagement metrics hold up under alternative feature-weighting schemes, and that the findings extend to the level of metagenome-assembled genomes, not just reference species. Importantly, the team has released an R package, IMGI, that computes both scores, lowering the barrier for other groups to apply the framework to their own cohorts. The authors note a pending patent application related to immunomodulatory scoring for personalized medicine, though they state it did not influence the study’s design or interpretation.

The conceptual payoff of the study may ultimately matter more than any single clinical result. By demonstrating that IgA targeting is conserved across populations, disrupted in a defined neurological disease, and responsive to intervention, the work establishes antibody-mediated surveillance as a quantifiable organizing axis of gut microbiota structure — a third dimension alongside taxonomy and function. It reframes the microbiome not as a free-floating ecological community but as one continuously curated by the host immune system, with that curation itself carrying diagnostic and prognostic information. If the findings replicate broadly, microbiome studies of the future may routinely report immune engagement alongside abundance, and diseases currently studied through compositional lenses may be re-examined through the antibody layer that has been coating the data all along.

There are, of course, caveats inherent to any observational framework of this kind. IgA binding reflects immune recognition, but the causal direction of the relationship — whether antibodies actively shape community structure, or simply mirror it — remains an open question that the correlational data cannot fully resolve. The multiple sclerosis findings come from early-stage disease and specific cohorts, and the index’s performance as a longitudinal biomarker will need validation in larger, prospective studies before it can inform clinical decisions. Still, the study provides something the field has lacked: a standardized, reproducible, and openly implemented way to measure the immune-microbiota interface. For a discipline that has spent fifteen years cataloguing microbial residents, the message is that the landlord’s fingerprints are everywhere — and now they can finally be counted.

Subject of Research: IgA-mediated immune surveillance as a quantitative organizing axis of gut microbiota structure in health and early multiple sclerosis

Article Title: Antibody-mediated immune surveillance as an organizing axis of gut microbiota structure

Article References: Nthuku, S., Sterlin, D., Pons, N., Parizot, C., Larsen, M., Rastetter, A., Marie, Y., Vicart, S., Maillart, E., Papeix, C., Gorochov, G., & Imamovic, L. (2026). Antibody-mediated immune surveillance as an organizing axis of gut microbiota structure. Microbiome. https://doi.org/10.1186/s40168-026-02542-2

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02542-2

Keywords: gut microbiota, immunoglobulin A, IgA-seq, immune surveillance, mucosal immunity, microbiome, multiple sclerosis, short-chain fatty acids, fecal microbiota transplantation, host-microbe interactions, metagenomics, Coprococcus comes

The logic of the approach is elegantly simple. If a phage attacks only one host species, then adding that phage to a complex community is equivalent to performing a surgical deletion experiment: the targeted bacterium is depleted while the rest of the community, at least in principle, remains untouched. Any subsequent changes in the abundance or behavior of other members can then be attributed to the loss of the depleted organism, providing the kind of causal evidence that observational metagenomics alone cannot deliver. Despite this potential, phages have rarely been harnessed for this purpose, largely because isolating viruses with sufficiently narrow host ranges against ecologically relevant bacteria has been a technical bottleneck.

Hessler and colleagues overcame that bottleneck for the bacterial genus Variovorax, a group of soil and rhizosphere bacteria that has emerged as a key player in plant-associated communities. The team isolated nine phages that replicate in several ecologically important Variovorax species. Host-range testing showed that these viruses are strikingly specific: spot assays across multiple Variovorax strains revealed that only one of the nine phages, V45_66, was able to form plaques on more than a single host. That narrow specificity is precisely what makes the phages useful as experimental scalpels, since a broad-host-range virus would trigger cascading effects that would confound the interpretation of any community-level changes.

The researchers’ first test case came from a long-standing hypothesis about vitamin sharing. Variovorax had been predicted, on the basis of correlation network analyses, to engage in thiamine interdependencies with other community members—meaning that some organisms might rely on Variovorax to supply this essential B vitamin, or vice versa. To test this, the team worked with complex enrichment communities containing between 18 and 31 bacterial species, grown in the laboratory on different carbon sources including guar gum, locust bean gum, arabinogalactan, and konjac gum. These communities were allowed to stabilize over repeated passages, with pairwise Bray–Curtis dissimilarity analysis showing that their composition settled into a steady state by day eight to ten of the experiment.

Into these stabilized communities, the researchers introduced three of their Variovorax-specific phages, either individually or as a cocktail, targeting a strain designated Variovorax SCN45. Genome-resolved metagenomics—a technique that reconstructs the genomes of individual community members from mixed sequencing data and tracks their relative abundances over time—revealed a consistent reduction in Variovorax across all four enrichment cultures following phage application. Crucially, the depletion did not stop with Variovorax. One other population, a bacterium belonging to the genus Leifsonia, declined in relative abundance once its putative partner was gone, exactly as the correlation-based hypothesis of thiamine interdependence had predicted.

The decisive experiment came next. If Leifsonia was collapsing because it had lost access to Variovorax-produced thiamine, then simply adding thiamine to the culture should rescue it. That is precisely what the researchers observed: supplementation with 10 milligrams per liter of thiamine restored the Leifsonia population. Differential abundance screening, combined with statistical testing across the pre-phage, post-phage, and post-phage-plus-thiamine conditions, identified the Leifsonia population and two members of the family Microbacteriaceae as likely dependents on Variovorax-derived thiamine. Metagenome-assembled genome data for Leifsonia were consistent with the amplicon sequence variant analysis, and gene fitness profiling by RB-TnSeq showed that Variovorax SCN45 carries a complete thiamine biosynthesis operon alongside a type IV secretion system, both of which were highlighted in the community context. Together, these lines of evidence confirmed thiamine production as the mechanistic basis for the interdependence between Variovorax and Leifsonia, converting a statistical association into a verified biochemical relationship.

The team then extended the approach to a second, entirely different experimental system: a defined rhizosphere co-culture grown with Arabidopsis plants. In this system, a strain called Variovorax CL14 is known to degrade the plant hormone auxin produced by another bacterium, Arthrobacter CL28. Auxin is a central regulator of plant growth, and its degradation by Variovorax modulates how the plant responds to its microbial residents. Using phages v.cl_11 and v.cl_23, the researchers eliminated Variovorax CL14 from the co-culture. The result was a re-establishment of the stunted root phenotype, demonstrating that removing the auxin-degrading bacterium allowed the hormone to accumulate and suppress root growth. Growth curve experiments confirmed that the phages had no direct effect on Arthrobacter CL28 itself, reinforcing the specificity of the manipulation.

Beyond the specific findings about thiamine and auxin, the study carries a broader methodological significance. The enrichment communities in the experiments were monitored for stability, and haplotype frequency analysis was used to track evolutionary changes associated with phage exposure, giving the researchers a window into both ecological and evolutionary responses to viral attack. Supplementary analyses showed that the summed relative abundance of organisms encoding complete thiamine biosynthesis pathways shifted predictably across the experimental stages, and that the phage-induced perturbations were reproducible across independent carbon-source enrichments. This level of internal consistency strengthens the case that phage-mediated depletion can serve as a general-purpose tool for causal inference in microbiome science, complementing approaches such as gnotobiotic reconstruction, metabolic modeling, and isotope tracing.

The implications reach well beyond the laboratory. Microbiomes govern processes of enormous practical importance—from nutrient cycling in soils and plant health in agriculture to the functioning of bioreactors and, in medicine, the balance of human gut communities. A technique that allows researchers to remove a single species from a functioning community and observe the consequences could accelerate the identification of keystone organisms, the validation of cross-feeding networks, and ultimately the rational design of synthetic microbial consortia. The authors note that their experiments lay the foundation for research employing both wildtype and engineered phages to test interaction hypotheses and for targeted microbiome manipulation. Engineered phages, in particular, could in principle be designed to deliver payloads or to tune depletion dynamics with even finer control.

There are, of course, caveats and open questions. Phage infection itself can trigger physiological changes in the target host before lysis, and phage replication may impose selection pressure on the community, as suggested by the haplotype dynamics observed in this study. Host-range specificity, while an asset here, must be established case by case, and not every ecologically important bacterium has a culturable phage. Nevertheless, the demonstration that nine narrow-host-range phages could be isolated against Variovorax, and that three of them could cleanly test a metabolic interdependence hypothesis inside communities of up to 31 species, marks a substantial advance. The work, supported by the U.S. Department of Energy’s m-CAFEs Science Focus Area at Lawrence Berkeley National Laboratory, suggests a future in which viruses—long studied as pathogens of bacteria—become routine instruments for dissecting the hidden wiring of microbial ecosystems, one species at a time.

Subject of Research: Phage-based depletion of Variovorax to test microbial interactions in intact microbiomes

Article Title: Phage-based depletion of Variovorax reveals interactions within intact microbiomes

Article References: Hessler, T., Chiniquy, D., Adler, B. A., Hoff, J., Tucker, E., Huddy, R. J., Sachdeva, R., Lei, S., Harrison, S. T. L., Barrangou, R., Diamond, S., Deutschbauer, A. M., & Banfield, J. F. (2026). Phage-based depletion of Variovorax reveals interactions within intact microbiomes. Microbiome. https://doi.org/10.1186/s40168-026-02539-x

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02539-x

Keywords: bacteriophages, microbiome, Variovorax, thiamine, cross-feeding, metagenomics, rhizosphere, Arabidopsis, auxin, Leifsonia, microbial interactions, phage therapy

The research focused on the blunt snout bream (Megalobrama amblycephala), an economically important omnivorous freshwater fish farmed widely in China, and the Chinese perch (Siniperca chuatsa), a carnivorous predator from a different family. By exposing bream eggs to perch sperm, the team produced natural gynogenetic blunt snout bream, abbreviated GBSB. Because gynogenesis normally blocks the paternal genome, these offspring carry essentially maternal genetics. Yet the researchers suspected that the heterologous sperm, the sperm of a different species, might still influence early developmental events, and that these influences could cascade into differences in physiology, digestion, and the gut microbiome that persist into later life.

To test this idea, the team collected intestinal tissues from the gynogenetic bream, from normal blunt snout bream, and from both parental species. They then applied a battery of complementary techniques: metagenomic sequencing to catalogue the gut microbial communities and their functional genes, histological examination to inspect gut structure under the microscope, enzyme activity assays to measure digestive and antioxidant capacity, and quantitative gene expression analysis to track the activity of key metabolic genes. Finally, Pearson correlation analysis was used to link the abundance of microbial functions with the expression levels of host metabolic genes, providing a statistical bridge between the microbiome and the fish’s own biochemistry.

The first striking result concerned digestive performance. The intestines of the gynogenetic bream showed higher activity of several digestive enzymes than those of normal blunt snout bream, including alkaline xylanase, acid phosphatase, and lipase. These enzymes break down plant fibers, phosphorus-containing compounds, and fats respectively, and elevated activity suggests the gynogenetic fish were better equipped to extract energy and nutrients from their food. The gynogenetic fish also displayed stronger antioxidant defenses, with higher levels of catalase activity and reduced glutathione, molecules that protect tissues from the damaging reactive oxygen species generated during normal metabolism and stress.

Metabolic gene expression told a subtler story. In the gynogenetic bream, the expression of glycolysis-related genes, including GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and Idha (isocitrate dehydrogenase alpha), was downregulated compared with the maternal line. Glycolysis is the classic first step of glucose breakdown, converting sugar into pyruvate for energy. In contrast, genes of the pentose phosphate pathway, Pgd (phosphogluconate dehydrogenase) and Taldo1 (transaldolase 1), were upregulated. The pentose phosphate pathway is a parallel glucose-processing route that generates NADPH, a reducing agent crucial for antioxidant defense and biosynthesis, along with ribose sugars for DNA and RNA production. This shift suggests the gynogenetic fish may be channeling glucose away from straightforward energy production and toward cellular maintenance and protection, consistent with their elevated antioxidant capacity.

The gut microbiota analysis revealed a pattern of both continuity and change. Overall, the microbial community in the gynogenetic bream closely resembled that of the maternal parent, with the genus Bacillus dominating in both. This maternal inheritance of gut microbes is not surprising, since gynogenetic offspring develop from maternal eggs and are reared in similar environments, and gut microbiota in fish is shaped heavily by diet, environment, and vertical transmission. However, the researchers did detect shifts within two major bacterial phyla, Bacteroidota and Pseudomonadota, indicating that the gynogenetic process was not without microbial consequences. These phyla include many species involved in carbohydrate fermentation and the production of short-chain fatty acids, metabolites that feed the gut lining and influence host metabolism.

Perhaps the most intriguing finding came from the correlation analysis linking microbial functions to host gene expression. The data suggested that the heterologous sperm induction altered host gene expression, and that these changes in the host in turn drove a restructuring of the gut microbiota through host-microbiota interactions in sugar metabolism. In other words, even though the perch sperm contributed no genes to the offspring’s genome, its role in triggering development appears to have set off a chain of physiological adjustments in the fish, and those adjustments selected for a somewhat different community of gut microbes. This host-first model, in which the animal’s own metabolic state shapes which microbes thrive, offers a mechanistic explanation for how a purely maternal genome can end up with a subtly different microbiome than its mother.

The broader significance of the work lies in aquaculture. Gynogenesis is a valuable tool for fish breeders because it rapidly produces highly inbred, nearly homozygous lines, which can then be used to create hybrid vigor or fixed desirable traits. Blunt snout bream is a cornerstone species of Chinese freshwater aquaculture, and improving its digestion, growth efficiency, and disease resistance has direct economic value. The finding that microhybridization can enhance digestive enzyme activity and antioxidant capacity suggests that gynogenetic lines may carry practical advantages, but also that their altered glucose metabolism means feeding strategies designed for ordinary bream may not be optimal for gynogenetic stock. The authors note that these host metabolism-microbiota dynamics are crucial for optimizing feeding strategies and health management in novel gynogenetic fish breeds.

The study also fills a genuine gap in the scientific literature. Although gut microbiota is recognized as a critical player in host nutrition and metabolism across the animal kingdom, research on the intestinal physiology and microbiomes of gynogenetic offspring, particularly those produced by crossing an omnivorous mother with a carnivorous father, has been scarce. By combining metagenomics, histology, enzymology, and gene expression profiling in a single comparative framework spanning three fish types, the Hunan Normal University team, led by corresponding authors Ping Wu, Qizhi Liu, and Shaojun Liu, has provided one of the most complete pictures to date of how gynogenesis reverberates through the gut axis of a farmed fish.

Looking ahead, the work raises questions that extend well beyond bream. If the mere act of fertilization by foreign sperm can shift host metabolism and microbiome composition in gynogenetic offspring, similar effects might operate in other systems where interspecific sperm exposure occurs, including hybridization events in wild fish populations and assisted reproduction techniques in conservation programs. The interplay between the pentose phosphate pathway, antioxidant defenses, and microbial community structure also mirrors themes familiar from human metabolic research, where gut microbes and host glucose handling are tightly intertwined. For now, the gynogenetic bream stands as a vivid example that reproduction is more than genetics: the cellular drama of fertilization itself can echo through the gut, the microbiome, and the metabolic machinery of an entire organism.

Subject of Research: Effects of microhybridization on gut microbiota and glucose metabolism in gynogenetic blunt snout bream

Article Title: Microhybridization enhances intestinal microbiota and glycometabolic regulation in natural gynogenic blunt snout bream derived from the blunt snout bream (Megalobrama amblycephala, ♀) × Chinese perch (Siniperca chuatsi, ♂)

Article References: Wei, Y., Dai, R., Hu, M., Lei, S., Tang, J., Weng, S., Zeng, Y., Ding, Y., Qin, Q., Yi, T., Wang, M., Tao, M., Zhang, C., Wu, P., Liu, Q., & Liu, S. (2026). Microhybridization enhances intestinal microbiota and glycometabolic regulation in natural gynogenic blunt snout bream derived from the blunt snout bream (Megalobrama amblycephala, ♀) × Chinese perch (Siniperca chuatsi, ♂). BMC Genomics. https://doi.org/10.1186/s12864-026-13359-6

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13359-6

Keywords: gynogenesis, microhybridization, gut microbiota, blunt snout bream, Chinese perch, glucose metabolism, glycolysis, pentose phosphate pathway, digestive enzymes, aquaculture, host-microbe interactions, metagenomics

The research, led by Priyaranjan Mandal and Kamesh R. Babu at UPES in Dehradun, India, together with colleagues Sourabh Behra and Aarika Kasliwal, set out to answer a question that has quietly emerged as worm labs have changed how they feed their animals. Increasingly, researchers studying metabolism, aging, and host-microbe interactions kill the food bacteria with paraformaldehyde, or PFA, before putting them on the plates. Dead bacteria cannot reproduce, which prevents the food source from metabolically confounding the experiment. But if the bacteria are never going to proliferate, the peptone that exists to support that proliferation loses its purpose, and it may instead serve as a nutrient source for contaminating organisms.

The team systematically compared conventional NGM with a peptone-free version, using PFA-killed OP50, the standard laboratory strain of E. coli, as the sole food source in both cases. The results were striking. On conventional plates, residual bacterial proliferation persisted despite the killing procedure, and fungal contamination appeared more readily. On plates lacking peptone, residual bacterial growth was completely prevented and fungal contamination was markedly reduced. The peptone, it turns out, had been acting as an unintended growth substrate, undermining the very experimental control that PFA-killed bacteria are meant to provide and destabilizing cultures over time.

A natural concern was that removing a protein-rich nutrient from the medium might starve the worms or alter their biology in subtle ways that would confound downstream measurements. The researchers therefore ran a battery of standard physiological assays. Worms raised on peptone-free medium grew at a normal rate, reproduced normally, produced embryos with normal viability, lived a normal lifespan, and navigated chemotactic gradients with intact behavioral precision. In other words, the core biological outputs that most worm experiments measure were unchanged. The animals could not tell the difference in any way that matters for standard phenotyping, even though the chemical composition of their environment had shifted substantially.

Some behaviors did change. Worms on the peptone-free diet showed reduced food preference and reduced pharyngeal pumping, the muscular swallowing motion that constitutes worm feeding. Because the bacteria were dead and non-proliferating, the animals were presumably responding to a thinner or less attractive bacterial lawn, one that no longer received nutritional supplementation from the underlying medium. This is a meaningful consideration for experiments focused specifically on feeding behavior, and the authors note that it is one of the trade-offs of the modified recipe. For studies of aging, stress biology, and metabolism, however, the preserved growth, fertility, lifespan, and chemotaxis suggest the change is physiologically benign in most respects.

Where the differences emerged most clearly was in the worms’ internal biochemistry. Animals cultured on peptone-free medium showed lower basal levels of intracellular reactive oxygen species, the chemically reactive molecules that accumulate as byproducts of metabolism and contribute to oxidative damage over time. They also accumulated less lipid. At the molecular level, these changes were accompanied by downregulation of genes involved in oxidative stress responses and in lipogenesis, the biochemical pathway that builds fatty acids. The pattern suggests that worms on the simplified diet experienced a milder baseline metabolic state, with less endogenous oxidant generation and less drive to store fat, rather than being forced into stress-response mode.

That biochemical shift translated into what the authors describe as enhanced physiological resilience. Worms grown on the peptone-free medium displayed greater locomotor activity than their conventionally raised counterparts, moving more vigorously across the agar surface. More remarkably, they survived significantly better under three different forms of imposed adversity: oxidative stress, ultraviolet radiation, and heat. The convergence of reduced baseline ROS, altered stress-gene expression, and improved resistance to multiple external stressors paints a coherent picture of animals in a more robust physiological condition, even though their gross development and reproduction appeared entirely normal.

The findings carry particular weight for the growing field of diet-aging research in worms, where the bacterial food source is now recognized as a major experimental variable. Studies in recent years have shown that different bacterial diets can alter fat storage, longevity trajectories, associative learning decline, and neuronal survival, and that the method used to kill the bacteria, whether by ultraviolet irradiation, heat, or chemical fixation, itself changes worm physiology. Against that backdrop, a medium change that reduces baseline oxidative stress and lipid accumulation while preserving lifespan is not a trivial technical footnote. It means that labs using PFA-killed bacteria on conventional NGM may be measuring worm biology through an unnecessary layer of medium-derived metabolic noise.

There are also practical advantages that extend beyond experimental cleanliness. Peptone is a variable, animal-derived reagent whose exact composition can differ between manufacturers and batches, introducing an uncontrolled source of plate-to-plate variation. Removing it simplifies the recipe, reduces cost, and eliminates a reagent that must be quality-controlled. The authors describe peptone-free NGM as a simple, inexpensive, and practical refinement of the conventional culture system, and the word refinement is chosen deliberately: the change does not create a new platform but tightens the reliability of one that has been in continuous use since Sydney Brenner established C. elegans as a genetic model organism in the 1970s.

For a model organism whose transparency, short lifespan, and genetic tractability have made it a workhorse of aging and disease research, small methodological improvements can ripple widely. The peptone-free protocol requires no special equipment, no genetic engineering, and no retraining; it is a subtraction rather than an addition. As labs that rely on metabolically inactivated bacteria adopt the modified medium, the study’s broader implication may prove to be about experimental reproducibility: the cleaner and more defined the culture environment, the more confidently researchers can attribute the biology they observe to their genes, drugs, and interventions of interest rather than to their plates.

Subject of Research: Effects of peptone-free nematode growth medium on culture stability and stress resilience in Caenorhabditis elegans

Article Title: Peptone-free nematode growth medium improves culture stability and physiological resilience in Caenorhabditis elegans

Article References: Mandal, P., Behra, S., Kasliwal, A., & Babu, K. R. (2026). Peptone-free nematode growth medium improves culture stability and physiological resilience in Caenorhabditis elegans. Biogerontology, 27(5), Article 169. https://doi.org/10.1007/s10522-026-10513-1

Image Credits: AI Generated

DOI: 10.1007/s10522-026-10513-1

Keywords: Caenorhabditis elegans, nematode growth medium, peptone, Escherichia coli OP50, paraformaldehyde, culture stability, reactive oxygen species, oxidative stress, lipid accumulation, lifespan, biogerontology, host-microbe interactions

The historical roots of the field stretch back further than many researchers realize. As the tutorial recounts, the earliest experiments in tissue self-organization date to 1907, when Wilson demonstrated that dissociated sponge cells could reassemble into functional organisms. Decades later, work by Holtfreter, Weiss and Taylor established the concept of tissue affinity and the remarkable capacity of embryonic cells to reconstitute organized structures from single-cell suspensions. Steinberg’s differential adhesion hypothesis in 1970 provided a theoretical framework for why cells sort themselves into coherent tissues. These classical observations laid the conceptual groundwork for the modern organoid revolution, which arrived in earnest in 2008 and 2009 with two landmark achievements: Eiraku and colleagues’ self-organized formation of polarized cortical tissue from embryonic stem cells, and Sato and colleagues’ demonstration that single Lgr5-positive intestinal stem cells could build complete crypt-villus structures in vitro without any mesenchymal niche.

Those two founding systems, intestinal and brain organoids, form the backbone of the new tutorial, and the authors deliberately chose them because they represent opposite ends of the organoid spectrum. Adult stem cell-derived intestinal organoids, sometimes called miniguts, are genetically stable, expandable over years and remarkably faithful to the epithelium they came from. Human pluripotent stem cell-derived brain organoids, by contrast, are developmental models that recapitulate embryonic neurogenesis, offering access to human brain biology that no other experimental system can provide. By walking through both, the tutorial illustrates how organoid choice depends entirely on the biological question at hand, whether that question concerns tissue homeostasis in the adult or the choreography of human development.

One of the most technically rich sections of the tutorial addresses cell fate decisions, the process by which stem cells commit to specific differentiated identities. In the intestine, regional and local signaling gradients, particularly the Wnt, BMP and Notch pathways, control where and when cells become absorptive enterocytes, mucus-secreting goblet cells, hormone-producing enteroendocrine cells, or tuft cells. The tutorial highlights how organoids allow researchers to manipulate these gradients with unprecedented precision. Experiments have shown that enteroendocrine cells switch their hormone expression profiles along the crypt-to-villus BMP signaling gradient, and that induced quiescence of Lgr5-positive stem cells enables the differentiation of hormone-producing cells. In brain organoids, timed and combinatorial treatments with extrinsic signals can specify ventral telencephalic identities, while minimizing exogenous signals drives rostral hypothalamic differentiation, demonstrating that the same self-organizing logic governs tissues as different as gut and brain.

The tutorial also devotes substantial attention to decrypting cell-cell communication, one of the most challenging problems in tissue biology. Organoids provide a contained system in which signaling networks can be measured at single-cell resolution using multiplexed single-cell analysis, and in which genetic reporters can mark specific populations in living tissue. Fluorescent gene tagging without double-strand DNA cleavage, ASCL2-responsive minigenes that label stem cell activity, and biosensors that quantify single-cell ERK dynamics have all been deployed in organoid systems. Machine learning tools such as OrganoidTracker now allow researchers to follow cell fate dynamics in space and time across entire organoids, converting what was once a static snapshot technology into a live-imaging platform capable of resolving the oscillatory signaling events that control cell fate decisions during intestinal homeostasis.

Genetic disease modeling represents perhaps the most clinically resonant application, and the tutorial lays out the strategies in detail. CRISPR-Cas9 engineering of organoids has enabled researchers to introduce precise mutations into otherwise healthy tissue, generating isogenic disease models. Sequential introduction of cancer mutations in cultured human intestinal stem cells has recapitulated colorectal cancer progression, while CRISPR-mediated engineering of patient-derived organoids has allowed systematic dissection of tumor evolution. On the repair side, functional correction of the CFTR gene by CRISPR in intestinal stem cell organoids from cystic fibrosis patients demonstrated that gene editing could restore disease-relevant function. The forskolin-induced swelling assay, which measures CFTR channel activity in patient-derived rectal organoids, has matured into a validated diagnostic tool, and high-throughput versions of the assay now support drug repurposing for cystic fibrosis.

Infectious disease research has been transformed by organoids as well. The tutorial documents how human intestinal organoids supported the first productive infection of human gut enterocytes by SARS-CoV-2, and how brain organoids became the central platform for understanding Zika virus-induced microcephaly. Multiple groups showed that Zika depletes neural progenitors through activation of the innate immune receptor TLR3, and organoid-based drug screens identified compounds that combat infection. Microinjection platforms and microfluidic gut-on-chip systems now allow controlled exposure of organoids to defined microbes, including complex anaerobic communities, opening the door to systematic study of host-microbiome interactions that were previously inaccessible in vitro.

The tutorial’s treatment of brain organoids extends into territory that borders on the philosophical. Comparative studies using organoids from human, chimpanzee and macaque cells have identified species-specific differences in progenitor behavior that contribute to brain size, and human-specific genes such as ARHGAP11B, NOTCH2NL and SRGAP2 have been shown to expand cortical neurogenesis when tested in organoid systems. Assembloids, fused organoids representing different brain regions, now model interneuron migration, thalamocortical connectivity and even the ascending sensory pathway. Single-cell brain organoid screening has revealed developmental defects in autism, and patient-derived organoids have exposed aberrant neuronal development in schizophrenia and copy number variant disorders. Chimeric models, in which human organoids are transplanted into mouse brains, have produced vascularized, innervated human tissue that establishes subcortical projections in the host animal.

The authors are candid about the field’s remaining challenges. Organoids lack vasculature, immune cells and mechanical cues from their native environment, limiting their maturation and long-term viability. Batch-to-batch variability, particularly in brain organoids, complicates reproducibility, and stress responses within cortical organoids can impair molecular subtype specification. Matrigel, the animal-derived matrix on which most organoids are grown, remains poorly defined, spurring development of synthetic alternatives and engineered materials whose stiffness can itself direct stem cell behavior. The tutorial highlights emerging innovations, including optogenetic control of gene expression, scaffold-guided morphogenesis that produces homeostatic mini-intestines, microfluidic vascularization, and bioprinting platforms that enable drug screening at single-organoid resolution, as the technologies most likely to close these gaps.

The translational trajectory of the field is already visible. Patient-derived organoid biobanks have predicted treatment responses in metastatic gastrointestinal cancers, tumor organoid and T-cell co-culture systems are being used to evaluate engineered immunotherapies, and glioblastoma organoids now serve as real-time avatars for assessing CAR-T cell responses. Organoid transplantation has repaired colitis in mouse models, alleviated traumatic brain injury and addressed short bowel syndrome in preclinical studies. What the Munich tutorial ultimately conveys is that organoids have crossed a threshold: they are no longer a promising curiosity but a mature experimental ecosystem, one whose protocols, pitfalls and possibilities are now documented well enough that any competent laboratory can begin interrogating biology with them.

Subject of Research: Organoid technologies for interrogating fundamental biology and disease

Article Title: Tutorial: interrogating biology using organoid technologies

Article References: Bugter, J. M., Schafer, S. T., & Rad, R. (2026). Tutorial: interrogating biology using organoid technologies. Nature Protocols. https://doi.org/10.1038/s41596-026-01447-6

Image Credits: AI Generated

DOI: 10.1038/s41596-026-01447-6

Keywords: organoids, intestinal organoids, brain organoids, stem cells, CRISPR, disease modeling, self-organization, cell fate, host-microbe interactions, drug screening, assembloids, Nature Protocols

The research team, led by Zhengkui Zhou of the State Key Laboratory of Animal Biotech Breeding at the Institute of Animal Science, Chinese Academy of Agricultural Sciences, focused on ducks—an economically important livestock species whose skin fat and intramuscular fat content directly determine both the market value and the nutritional quality of the meat. Fat deposition, the researchers note, is a critical indicator of the economic and nutritional worth of animal products, and among the many factors that regulate it, the cecal microbiota—the vast community of microbes inhabiting the cecum, the pouch at the junction of the small and large intestines—has emerged as a key player.

To untangle the relationship between genes, microbes, and fat, the team assembled two genetically distinct duck populations designed to maximize variation in both genome and microbiome. The first was a gradient consanguinity segregating population derived from a cross between Pekin ducks, a fat-rich breed prized for its thick subcutaneous fat, and Liancheng white ducks, a leaner line. The second was an F2 population produced by crossing Pekin ducks with Call ducks, a small bantam breed with dramatically different body composition. Together, these populations provided nearly 789 metagenomic samples, each yielding a full catalog of the microbial species present in the cecum alongside dense genomic data from the host birds.

The technological core of the study was metagenomic sequencing, a method that reads the collective DNA of an entire microbial community rather than targeting a single marker gene. This approach allowed the researchers to identify and quantify 921 distinct microbial species in the cecal contents. When the team analyzed these profiles across the two populations, they found that the community structure of the cecal microbiota shifted gradually alongside differences in the host genetic background. In other words, as the genome of the birds became more Pekin-like or more Liancheng-like, the microbial ecosystem inside them changed in a corresponding, measurable way.

Regression analyses then revealed something striking: 921 microbial species showed statistically significant associations with two key lipid deposition traits—the skin fat ratio, a measure of subcutaneous fat, and the intramuscular fat content, the fat marbled within breast muscle. This suggested a deep link between which microbes reside in the gut and where and how much fat the host accumulates.

But correlation alone could not settle the direction of causality. Does a fatty body create a microbe-friendly gut environment, or do particular microbes actively influence fat deposition? To begin answering this, the researchers turned the tools of human genetics onto the microbiome itself. Using genome-wide association analysis, or GWAS—a technique that scans the genome for DNA variants that correlate with a trait—they searched for host genes that modulate the relative abundance of specific gut microbes. The scan identified 18 candidate genes implicated in controlling microbial abundance in the cecum.

The functional picture that emerged from these genes was remarkably coherent. Fifteen of the 18 were functionally enriched in membrane-related signal transduction processes—the molecular machinery by which cells receive, interpret, and relay signals across their outer membranes. This finding points to a specific biological mechanism: host cells lining the gut appear to use membrane-based signaling pathways to sense and regulate the microbial populations around them. Rather than the immune system alone dictating which microbes thrive, the study suggests that genes governing cellular communication at the gut interface play a decisive role in shaping which bacterial species flourish.

Among the 18 candidate genes, two stood out because of their links to individual microbial species with clear connections to fat. The first gene, LIMS2, was genetically linked to Acinetobacter baumannii, a species whose abundance in the cecum tracked with lipid deposition in the host. LIMS2 encodes a protein involved in integrin signaling, a pathway central to how cells attach to their surroundings and transmit mechanical and chemical signals—processes with established roles in tissue architecture and metabolism. The researchers performed tissue-specific expression analysis showing that LIMS2 is expressed in relevant metabolic tissues, strengthening the case for its involvement.

The second gene, ST3GAL1, was linked to Akkermansia muciniphila, a microbe famous in biomedical research as a mucin-degrading bacterium associated with leanness and metabolic health in mammalian studies. ST3GAL1 encodes an enzyme that adds sialic acid residues to glycoproteins—molecules that stud cell surfaces and the protective mucus layer of the gut. Because Akkermansia feeds directly on the mucus lining, a host gene that chemically modifies that mucus could plausibly determine how hospitable the gut environment is to the bacterium. The GWAS signal for Akkermansia muciniphila mapped to a quantitative trait locus on chromosome 2, and supplementary analyses showed that this region differentiates fat-type Pekin ducks from lean Liancheng white ducks, and that expression of ST3GAL1 itself is genetically regulated in that interval.

Perhaps the most consequential result was the demonstration that the genetic loci controlling microbial abundance overlapped with the loci influencing fat deposition itself. The researchers built genetic correlation networks linking specific microbial taxa to host lipid traits and modeled the combined additive effects of two lead GWAS loci on both skin fat ratio and intramuscular fat content. The results support a model in which host genetic variants influence fat phenotypes partly by tuning the gut microbial ecosystem—an indirect pathway running from DNA, through the microbiome, to the fat tissue.

The implications extend well beyond duck breeding. First, for agriculture, the findings open the possibility of selecting breeding stock not only for fat traits directly, but also for the gut microbial profiles those genes encourage—potentially allowing producers to modulate fat deposition through a combination of genetics and microbiome management. Second, for biomedical science, the discovery that membrane signal transduction genes regulate specific gut bacteria such as Akkermansia muciniphila provides a genetically grounded framework for understanding why microbiome-based therapies show such variable results between individuals: the host genome may largely determine whether a beneficial microbe can establish itself.

It is also a methodological milestone. Microbiome GWAS—linking host genetic variation to the abundance of individual microbial species rather than broad community measures—has been attempted in humans and model organisms, but studies that simultaneously connect microbes, host genes, and a quantitative economic trait like fat deposition remain rare. By using segregating duck populations with extreme and continuous variation in fat phenotypes, the team created a natural experiment in which the effects of host genetics on the microbiome could be cleanly separated from confounders such as diet, age, and environment, all of which were controlled within the populations.

The study also adds nuance to the biology of lipid deposition itself. Skin fat and intramuscular fat are distinct depots with different metabolic roles and different commercial implications. The finding that hundreds of microbial species associate with both traits suggests the gut microbiome exerts broad influence over lipid metabolism, while the identification of specific microbe–gene pairs implies that individual microbial species may have targeted effects on particular fat depots.

The work was supported by the National Natural Science Foundation of China, the Innovation Program of the Chinese Academy of Agricultural Sciences, the China Agriculture Research System, and Hebei Leshou Duck Industry Co., Ltd. All animal protocols were reviewed and approved under the ethics regulations of the Institute of Animal Science. The article, published open access, will be of interest to geneticists, microbiome researchers, animal breeders, and metabolic biologists alike.

As microbiome science matures, the central question is shifting from whether the microbiome matters to how the host governs it. This study provides a compelling answer in one corner of the animal kingdom: through membrane signal transduction genes that reach out, biochemically, to the microbial residents of the gut—and in doing so, help write the recipe for body fat.

PIEMs are defined as microorganisms that persist in extraintestinal environments in a latent or low-replication state. Their defining features include tropism for specific host cell types, persistence-driven latency/reactivation dynamics, and the ability to modulate host physiology over long timescales rather than through rapid, acute infections.

Unlike conventional microbiota studies that emphasize abundance and community composition, this framework prioritizes persistence, cellular localization, and regulatory potency. Over years or decades, PIEMs are proposed to function as “systemic tuning devices,” subtly shifting immune set points, vascular homeostasis, metabolic baselines, and tissue repair capacity.

The review uses human cytomegalovirus (HCMV) as a mechanistic model. HCMV’s high prevalence, lifelong latency, broad cell tropism, and strong immune-modulating capacity make it well suited to map how a persistent intracellular infection can continuously “negotiate” with the host.

Mechanistically, the paper highlights pathways by which persistent HCMV may remodel antigen presentation, reshape T-cell memory, influence angiogenesis, and reprogram cellular metabolism. The authors suggest that such chronic interactions could contribute to complex diseases including autoimmunity, atherosclerosis, and cancer—not as single-cause agents, but as long-term risk modifiers.

A major challenge in PIEM research is detection: low microbial loads make direct observation difficult. To address this, the review proposes a liquid-biopsy approach using circulating viral microRNAs as reporters of ongoing viral activity. The authors emphasize that microRNA signals may track real-time latency dynamics rather than only historical exposure.

Building on prior validation by Zhang’s team, the review notes that viral miRNA biomarkers have shown promise in multiple clinical contexts, including prediction of hepatitis B treatment response and auxiliary diagnosis of oral lichen planus. This positions PIEM monitoring as a potential route toward more dynamic, precision-style interventions.

Overall, the PIEM concept expands microbiome research into an internal, cell-centered “latent infection” paradigm. It also points toward virome-driven precision medicine, where multi-omics and artificial intelligence could support individualized risk assessment, monitoring, and targeted intervention.

Subject of Research: Not applicable
Article Title: Beyond the gut microbiome: human cytomegalovirus as a model for persistent intracellular extraintestinal microbes in human homeostasis and disease
News Publication Date: 20-Jul-2026
Web References: http://dx.doi.org/10.1007/s44466-026-00048-y
References: 10.1007/s44466-026-00048-y
Image Credits: Credit: Professor Chen-Yu Zhang from Nanjing University, China

Keywords: persistent intracellular extraintestinal microbes (PIEMs); cytomegalovirus; latency/reactivation; microRNA biomarker; liquid biopsy; immune calibration; host homeostasis

Delving deep into the oral microbiome landscape, this investigation identified that individuals possessing the ABO*A1 allele have an elevated abundance of a glycoside hydrolase gene within Prevotella nanceiensis strains. This enzyme is hypothesized to cleave histo-blood group antigens, specifically those of the A type, thereby facilitating microbial adaptation and presumably providing a nutritional advantage to these bacteria. Strikingly, this association became evident only in persons who are genetic secretors, carrying functional FUT2 alleles, which enable the expression of histo-blood group antigens on mucosal surfaces.

The FUT2 enzyme, encoded by the FUT2 gene, governs the synthesis of type I H antigens on epithelial cells and in secretions. In secretor individuals, these antigens can be further glycosylated into A or B antigens according to the ABO genotype. The study uncovered that secretors with A or AB blood types manifested a 71-77% prevalence of the glycoside hydrolase gene in their oral microbiomes. In contrast, non-secretors or individuals with B or O blood types had significantly lower prevalence rates of 46-48%, underscoring a selective pressure exerted by the host glycosylation pattern on the microbial genetic repertoire.

Through meticulous genomic analysis, the glycoside hydrolase locus, initially annotated as a pseudogene due to presumed truncation, was found to exist as a full-length enzyme homologous to GH95 family α1,2-fucosidases present in Prevotella salivae. This revelation was based on assembly of unmapped reads, which suggested that the bacteria possess the enzymatic machinery to cleave α1,2-fucosyl bonds—components integral to the host’s glycan structures. This ability points toward a mechanism wherein Prevotella leverages host-derived glycans as substrates, thus tightly intertwining bacterial survival strategies with host blood group biology.

Intriguingly, the research indicated a graded influence of different ABO alleles on glycoside hydrolase gene presence, reflective of their varied capacities to produce A antigens. Individuals heterozygous for B alleles demonstrated an antagonistic effect on gene abundance when paired with A1 or A2 alleles, suggesting biochemical competition between A and B glycosyltransferases for modifying histo-blood group antigens. This nuanced genetic interplay highlights the sophistication of host-driven ecological niche construction in microbial communities.

Opposite to the findings in Prevotella, a parallel genomic locus in Rothia mucilaginosa demonstrated an inverse relationship with ABO blood groups, where A, B, and AB blood types correlated with absence rather than presence of specific genetic regions. This association intriguingly occurred irrespective of secretor status, suggesting alternative, FUT2-independent pathways in which ABO influences microbial landscape, possibly involving interactions with blood and endothelial cell-derived antigens synthesized via FUT1 pathways.

Further, the persistence of ABO*A1 genotype effects on microbiome composition in non-secretors implies that ABO blood group modulation of the oral microbial niche transcends FUT2-dependent antigen expression. This raises the prospect that host immune components, such as anti-A and anti-B antibodies produced by plasma cells infiltrating the oral mucosa, contribute to selective pressures shaping bacterial colonization and genetic adaptations. Indeed, bacteria might exploit or mimic host glycans to evade immune surveillance or facilitate colonization, representing a subtle battleground at the molecular interface of host and microbe.

The implications of these findings reverberate beyond academic curiosity; they underscore the intricate co-evolution of human genotypes and microbial communities. Understanding how host blood group antigens dictate bacterial gene content opens new avenues for predicting susceptibility to oral diseases, tailoring personalized dental care, and potentially manipulating microbiomes through glycan-targeting therapies. Prevotella’s enzymatic capacity to utilize A antigens hints at microbiome-mediated nutrient cycling intimately linked to host genotype, a paradigm shift in appreciating the oral ecosystem’s dynamic complexity.

Moreover, this research bridges a critical gap by connecting glycosylation genetics—long studied in immunology and transfusion medicine—to microbial ecology and functional genomics. The notion that host blood type genes can sculpt microbial genetic architectures positions human genetics as an active architect of microbial community function, challenging simplistic views of host-microbe relationships and suggesting a woven evolutionary tapestry shaped by molecular recognition and metabolic interplay.

The study’s use of whole genome sequencing (WGS) metagenomic data, encompassing over 10,000 individuals, marks a significant methodological advance. High-resolution binning of genomic coverage exposed subtle yet pervasive host-genome-microbiome interactions, revealing key microbial genes influenced by human variation. This scalable approach heralds a new era in microbiome research, where integrating human and microbial genomes yields predictive frameworks for health and disease modulation.

Notably, the occurrence of specific glycoside hydrolase genes in bacteria aligns with the proposed enzymatic adaptation to host-derived carbohydrate motifs. The putative cleavage of α1,2-fucosyl linkages by Prevotella’s glycoside hydrolase underscores a tailored microbial strategy to exploit mucosal glycans, analogous to mechanisms reported in the gut microbiome where bacterial enzymes degrade host glycans for nutrition and colonization advantage. This conserved biochemical theme across anatomical sites points to a universal axis of host-microbiome crosstalk mediated through glycobiology.

Equally astonishing is the discovery that ABO effects in Rothia manifest independently of secretor status, a phenomenon demanding further exploration. The genes implicated in Rothia include a 3-isopropylmalate dehydrogenase involved in leucine biosynthesis and a protein with unknown function, suggesting non-canonical metabolic or signaling roles connected to host blood group. Unraveling these pathways could reveal novel microbial mechanisms responding to host factors beyond classic glycosylation landscapes.

Collectively, these revelations articulate a compelling narrative: human genetic variation, particularly in ABO blood group and FUT2 secretor status, orchestrate microbial gene prevalence and thereby shape the oral microbiome at a fine scale. This genetic choreography unravels a sophisticated interface where host glycan diversity not only defines antigenicity and immune recognition but also constructs ecological niches and selective pressures influencing bacterial genetic and functional diversity.

This innovative research sets a foundation for future inquiries into how blood group alleles influence susceptibility to oral diseases, modulate microbiome resilience, and interact with host immunity. By decrypting molecular dialogues at the host-microbiome frontier, science moves closer to harnessing the oral microbiome as a therapeutic target, personalized according to host genetic backgrounds.

In summary, the study vividly demonstrates that oral microbiomes reflect a complex genetic interplay between host blood group polymorphisms and bacterial genomic adaptations. The glycoside hydrolase gene in Prevotella emerges as a keystone functional trait governed by ABO and FUT2 genotypes, revealing how microscopic enzymatic functions resonate with macroscopic human phenotypes. Through such integrative insights, the path forward unfolds toward precision medicine and microbiome-informed health strategies.

Subject of Research: Interactions between human ABO blood group genetics, FUT2 secretor status, and the oral microbiome’s bacterial genomic content, focusing on Prevotella and Rothia species.

Article Title: Human and bacterial genetic variation shape oral microbiomes and health.

Article References:
Kamitaki, N., Handsaker, R.E., Hujoel, M.L.A. et al. Human and bacterial genetic variation shape oral microbiomes and health. Nature (2026). https://doi.org/10.1038/s41586-025-10037-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-025-10037-7

Keywords: ABO blood group, FUT2 secretor status, oral microbiome, Prevotella, glycoside hydrolase, host genetics, microbial adaptation, histo-blood group antigen, metagenomics, host-microbe interaction, glycosylation, microbial genomics